Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Cockerham

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Expert Review of Medical Devices|May 3, 2008
Application of MEMS technology and engineering in medicine: a new paradigm for facial muscle reanimationKimberly Cockerham, Seppo Aro, Wentai Liu, et al.
Endocrinology, Diabetes & Metabolism Case Reports|March 23, 2022
Thyroid dermopathy responds to teprotumumab therapyRicaurte Crespo-Trevino, Jade Schiffman, Shoaib Ugradar, et al.
Frontiers in Ophthalmology|July 31, 2025
Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatmentsJennifer Murdock, John Nguyen, Brady J Hurtgen, et al.
Frontiers in Ophthalmology|April 29, 2025
The role of IL-6 in thyroid eye disease: an update on emerging treatmentsJennifer Murdock, John Nguyen, Brady J Hurtgen, et al.
American Journal of Ophthalmology Case Reports|June 11, 2021
Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter studyConnie M Sears, Yao Wang, Lucy A Bailey, et al.
Eye (London, England)|July 10, 2021
Teprotumumab for the treatment of chronic thyroid eye diseaseShoaib Ugradar, Julia Kang, Andrea L Kossler, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 10, 2024
Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility ValuesTerry J Smith, Kimberly Cockerham, Naina Barretto, et al.
JAMA Ophthalmology|December 29, 2022
Utility Assessment of Moderate to Severe Thyroid Eye Disease Health StatesTerry J Smith, Kimberly Cockerham, Gary Lelli, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 13, 2024
Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case seriesShoaib Ugradar, Emanuil Parunakian, Emil Malkhasyan, et al.
Ophthalmic Plastic and Reconstructive Surgery|November 16, 2023
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye DiseaseClara J Men, Linus Amarikwa, Brandon Pham, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Expert Review of Medical Devices|May 3, 2008
Application of MEMS technology and engineering in medicine: a new paradigm for facial muscle reanimationKimberly Cockerham, Seppo Aro, Wentai Liu, et al.
Endocrinology, Diabetes & Metabolism Case Reports|March 23, 2022
Thyroid dermopathy responds to teprotumumab therapyRicaurte Crespo-Trevino, Jade Schiffman, Shoaib Ugradar, et al.
Frontiers in Ophthalmology|July 31, 2025
Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatmentsJennifer Murdock, John Nguyen, Brady J Hurtgen, et al.
Frontiers in Ophthalmology|April 29, 2025
The role of IL-6 in thyroid eye disease: an update on emerging treatmentsJennifer Murdock, John Nguyen, Brady J Hurtgen, et al.
American Journal of Ophthalmology Case Reports|June 11, 2021
Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter studyConnie M Sears, Yao Wang, Lucy A Bailey, et al.
Eye (London, England)|July 10, 2021
Teprotumumab for the treatment of chronic thyroid eye diseaseShoaib Ugradar, Julia Kang, Andrea L Kossler, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 10, 2024
Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility ValuesTerry J Smith, Kimberly Cockerham, Naina Barretto, et al.
JAMA Ophthalmology|December 29, 2022
Utility Assessment of Moderate to Severe Thyroid Eye Disease Health StatesTerry J Smith, Kimberly Cockerham, Gary Lelli, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 13, 2024
Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case seriesShoaib Ugradar, Emanuil Parunakian, Emil Malkhasyan, et al.
Ophthalmic Plastic and Reconstructive Surgery|November 16, 2023
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye DiseaseClara J Men, Linus Amarikwa, Brandon Pham, et al.
Pageof 3